Table 2. Description of Parkinson’s disease costs during the four years of study.

	Year 1				Year 2				Year 3				Year 4
	Mean €	SD €	Range €	n	Mean	SD	Range	n	Mean	SD	Range	n	Mean	SD	Range	n
Direct costs	1,330.51	2,229.77	16.65–20,948.08	174	1,088.20	1,966.87	2.03–22,298.30	174	1,819.49	3,008.92	25.2–22,620.09	174	2,022.90	4,582.78	25.37–51,180.60	166
Medical	998.38	1,476.15	8.10–10,442.78	174	763.66	729.10	2.03–6,461.14	174	914.34	1,027.60	12.15–9,261.79	174	1,525.00	4,321.92	25.37–51,180.60	166
Pharmacological	284.39	241.87	0.00–1220.07	174	393.76	355.21	0.00–3132.94	174	466.00	347.89	5.40–1602.88	174	516.48	458.92	0.00–3807.27	174
Non-medical	1,090.40	2,781.15	6.00–19,857.60	53	1,660.88	3,853.10	6.30–22,063.80	34	4,144.66	4,715.82	15.00–20,157.66	38	2,850.10	2,839.70	20.00–8,903.56	29
Indirect costs	1,720.90	2,176.90	21.38–12,830.48	76	1,865.30	4,916.66	21.38–44,812.88	85	2,062.48	4,947.42	21.38–44,775.36	93	3,931.40	8,372.62	37.52–55,680.62	92
Total Costs	2,082.17	2,889.86	16.65–20,948.08	174	1,999.41	4,199.18	2.03–46,631.75	174	2,921.85	5,998.40	25.20–67,395.45	174	4,008.60	7,757.35	37.52–56,730.81	174

SD: standard deviation